ClinicalTrialsFinder

CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies Clinical Trials in Wuhan, Hubei

1 recruitingWuhan, Hubei, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

CART TherapyNK/T-cell LymphomaCD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology10 enrolled1 locationNCT06732492